Sign in

CIK 0001844417

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Estrella Immunopharma, Inc.

Sign in to watch
Ticker
ESLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
861314502
Phone
+1 510-318-9098
Business address
5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
Former names
TradeUP Acquisition Corp.

Securities

  • ESLA Common Stock Nasdaq
  • ESLAW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-02 Pussinen Cynthia Chief Executive Officer Grant or award · Stock Option (Right to Buy) +1,000,000 1,000,000
2026-08-25 Liu Cheng CEO Option exercise +100,000 $0.82 $82K 397,437
2026-08-25 Liu Cheng CEO Option exercise · Incentive Stock Option +100,000 900,000
2026-08-18 Xu Jiandong Chief Financial Officer Option exercise +100,000 $0.82 $82K 365,488
2026-08-18 Xu Jiandong Chief Financial Officer Option exercise · Incentive Share Option −100,000 390,796
2025-10-07 Xu Jiandong Chief Financial Officer Purchase +1,000 $1.33 $1K 265,488
2025-09-22 Xu Jiandong Chief Financial Officer Purchase +1,000 $1.16 $1K 16,700
2025-09-11 Xu Jiandong Chief Financial Officer Purchase +100 $1.04 $104 264,588
2024-10-30 Liu Cheng Chief Executive Officer Grant or award · Incentive Share Option +490,796 490,796
2024-10-30 Liu Cheng Chief Executive Officer Grant or award · Nonstatutory Share Option +509,204 509,203
2024-10-30 Xu Jiandong Chief Financial Officer Grant or award · Incentive Share Option +490,796 490,796
2024-10-30 Xu Jiandong Chief Financial Officer Grant or award · Nonstatutory Share Option +509,204 509,203
2023-09-29 Owl Creek Asset Management, L.P. 10% owner Other disposition −255,000 $10.86 $2.8M 0
2022-03-04 Li Jianwei Co-Chief Executive Officer Purchase +141,970 $314,700.00 $44.7B 1,253,730

Page 1 of 1 · 14 trades